Cargando…
Psoriasiform Eruption and Worsening of Pustulosis Palmoplantaris After Treatment with Two Anti-TNF-α Inhibitors, Followed by Successful Treatment with Ustekinumab
INTRODUCTION: Tumor necrosis factor (TNF)-α inhibitors are widely used for the treatment of inflammatory diseases. One of the side effects of TNF-inhibitors is the development of a psoriatiform eruption, also known as paradoxical psoriasis. In this case report, we describe a patient with this side e...
Autores principales: | Bogaards, Nathalie A., de Rie, Menno A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120639/ https://www.ncbi.nlm.nih.gov/pubmed/27783331 http://dx.doi.org/10.1007/s13555-016-0151-4 |
Ejemplares similares
-
Tumor necrosis factor‐α inhibitor‐induced follicular psoriasiform eruption
por: Goldberger, Tal, et al.
Publicado: (2022) -
Psoriasiform Drug Eruption Associated with Sodium Valproate
por: Gul Mert, Gulen, et al.
Publicado: (2013) -
Cyclosporine for refractory Kawasaki disease with psoriasiform eruption
por: Leyendecker, Mara, et al.
Publicado: (2021) -
Tozinameran: Psoriasiform drug eruption: case report
Publicado: (2022) -
Psoriasiform eruption on the face and extremities associated with nivolumab therapy
por: Om, Amit, et al.
Publicado: (2018)